Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury
Laurent Hudier(Hôpital Broussais), Cécile Vigneau(Inserm), A. Haddj-Elmrabet(Centre Hospitalier Universitaire de Rennes), T. Sawadogo(Centre Hospitalier de Bretagne Sud), P. Siohan(Centre Hospitalier de Cornouaille), Lise Mandart(Centre hospitalier Bretagne Atlantique), Emmanuel Oger(Hôpital Maison Blanche), Frank Bridoux(Université de Poitiers), T. Lamy de la Chapelle(Centre National de la Recherche Scientifique), Olivier Decaux(Hôpital Pontchaillou), Marie Lino(Centre Hospitalier Universitaire de Nantes), E. Renaudineau(Hôpital Broussais)
Cited by 10
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520